The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromes
about
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the ClinicDeregulation of innate immune and inflammatory signaling in myelodysplastic syndromesDefective proliferative potential of MSCs from pediatric myelodysplastic syndrome patients is associated with cell senescence.Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome.Dynamic alterations of bone marrow cytokine landscape of myelodysplastic syndromes patients treated with 5-azacytidine.Role of mesenchymal stem cells in cell life and their signaling.Mesenchymal stem cells in immune-mediated bone marrow failure syndromes.Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications.Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells.The bone-marrow niche in MDS and MGUS: implications for AML and MM.
P2860
Q26746104-BBAE3F3D-27BA-4086-A334-2CE9EB8F8A99Q26752778-E6A503E7-0C3D-4EB5-82EB-17B2B199C67EQ27015288-D25954CE-C04A-4312-BBCB-91D3AA4C5034Q36375313-9A21BD06-8BA7-494A-B180-03D76BF765BFQ36715982-F4BE668D-0B5A-4556-9229-0FE75EC5CF81Q37380379-90242C59-8829-4FBA-8748-5872954B8121Q37589437-B78312B2-8899-440B-9A97-CA96DB1B3B6CQ38175397-0B25C956-2639-4B8A-837E-8A6B751CE9B7Q41695046-17B704F1-7F72-4303-923D-4506704B8909Q42636758-CB5EA1D5-D718-4794-920C-EBD1976D2C10Q50114615-C12D475E-E6BB-4262-B0E1-B4895EF61473
P2860
The different immunoregulatory functions on dendritic cells between mesenchymal stem cells derived from bone marrow of patients with low-risk or high-risk myelodysplastic syndromes
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The different immunoregulatory ...... risk myelodysplastic syndromes
@ast
The different immunoregulatory ...... risk myelodysplastic syndromes
@en
The different immunoregulatory ...... risk myelodysplastic syndromes
@nl
type
label
The different immunoregulatory ...... risk myelodysplastic syndromes
@ast
The different immunoregulatory ...... risk myelodysplastic syndromes
@en
The different immunoregulatory ...... risk myelodysplastic syndromes
@nl
prefLabel
The different immunoregulatory ...... risk myelodysplastic syndromes
@ast
The different immunoregulatory ...... risk myelodysplastic syndromes
@en
The different immunoregulatory ...... risk myelodysplastic syndromes
@nl
P2093
P2860
P1433
P1476
The different immunoregulatory ...... risk myelodysplastic syndromes
@en
P2093
Weiming Li
Xiaoqiong Tang
Zhenling Wang
Zhigang Zhao
P2860
P304
P356
10.1371/JOURNAL.PONE.0057470
P407
P577
2013-03-04T00:00:00Z